Express News | Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements
ReutersApr 25 10:44 ET
Nexalin Technology Accelerates Manufacturing of Its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing
Mark White, CEO of Nexalin Technology, stated, "I am thrilled to report that the HALOClarity passed a series of rigorous tests, validating our manufacturing process and illustrating that our device meets the highest product standards.
GlobeNewswireApr 9 08:30 ET
Nexalin Technology Awarded Key Patent Related to Its Gen-3 HALO Clarity, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 17/337,653 relating to the Company's non-invasive, frequency-based deep brain stimulation device.
GlobeNewswireApr 4 13:00 ET
Nexalin Technology Unveils Positive Results of Clinical Study for Gen-2 TACS Device
Yahoo FinanceApr 4 11:05 ET
Nexalin Technology Full Year 2023 Earnings: US$0.63 Loss per Share (Vs US$0.30 Loss in FY 2022)
Yahoo FinanceMar 30 08:44 ET
Nexalin Technology Announces Positive Results of Clinical Study Validating Its Gen-2 TACS Device for Reducing Pain Among Veterans With Mild Traumatic Brain Injury at University of California, San Diego
Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group The data supports the Company's strategy to offer military and civilian
GlobeNewswireMar 28 08:30 ET
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology
HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) today announced that it has commenced sales of its second generation (Gen-2), 15 milliamp
GlobeNewswireMar 14 08:30 ET
Nexalin Technology Announces Poster Presentation at "State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment"
Event hosted by the U.S. Army Medical Research and Development Command's (USAMRDC) Combat Casualty Care Research Program (CCCRP) Neurotrauma Portfolio and the Biomedical Advanced Research and Development Authority
GlobeNewswireMar 13 08:30 ET
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
HOUSTON, TEXAS, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) today announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device,
GlobeNewswireFeb 8 08:30 ET
Nexalin Technology Awarded Key Patent Related to Its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S.
GlobeNewswireJan 23 08:30 ET
Nexalin Technology Unveils Next-Generation HALO Clarity
Yahoo FinanceJan 11 08:30 ET
Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of Its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms
HOUSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) today provided an update on the growing body of clinical data supporting the potential therapeutic
GlobeNewswireAug 7, 2023 08:30 ET
Nexalin's CEO Mark White to Be Interviewed Live on "The Big Biz Show" Today at 3PM Eastern Time
HOUSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) today announced that its Chief Executive Officer, Mark White, will be participat
GlobeNewswireAug 3, 2023 08:30 ET
Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin's TACS Devices in the Asia Pacific Region
HOUSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) today announced it has formalized a joint venture arrangement ("JV") with Wider Come Limited
GlobeNewswireJun 1, 2023 08:30 ET
No Data
No Data